Bohus BioTech AB is a Swedish biotechnology company specialized in research, development and manufacturing of high-quality hyaluronic acid raw material and products.
Employees: 11-50
Founded date: 1992
Investors 1
| Date | Name | Website |
| 25.04.2022 | Flerie Inv... | flerie.com |
Mentions in press and media 11
| Date | Title | Description |
| 24.02.2025 | Scottish BioTech Company Secures £3.4m Investment | Scottish biotech engineering company uFraction8 has secured £3.4m in new investment following the completion of a funding round led by the Foresight Group. Based in Falkirk with a fully-owned subsidiary in Poland, uFraction8’s microfiltrati... |
| 01.09.2024 | Noetik: AI-Based Biotech Company Raises $40 Million (Series A) To Develop Cancer Therapeutics | Noetik – an AI-based biotech company leveraging self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therapeutics – announced that it closed an oversubscribed $40 million Series A financing rou... |
| 13.08.2024 | Attorney General Tong Joins Multistate Coalition to Secure $4.5 Million from Biotech Company for Failing to Protect Health Data | Press Releases 08/13/2024 Attorney General Tong Joins Multistate Coalition to Secure $4.5 Million from Biotech Company for Failing to Protect Health Data (Hartford, CT) – Attorney General William Tong, along with the attorneys general of Ne... |
| 08.08.2024 | Healx Secures $47 Million to Tackle Rare Diseases with AI Innovations | In a significant leap for the biotech sector, Healx, a clinical-stage company based in Cambridge, UK, has successfully raised $47 million in a Series C funding round. This infusion of capital is not just a financial boost; it’s a lifeline f... |
| 07.08.2024 | Healx: Clinical-Stage Biotech Company Secures $47 Million In Series C | Healx, an AI-enabled, clinical-stage biotech company specializing in rare diseases, announced it has raised $47 million in a Series C round. This Series C round was co-led by Silicon Valley-based R42 Group and Atomico, one of Europe’s large... |
| 08.07.2024 | British Patient Capital invests £90m London biotech company | - |
| 22.12.2023 | Biotech company gets set for $15 million IPO | article-article-body Biotech company Genetic Signatures is set for a pre-Christmas listing on the Australian Securities Exchange on December 23, 2014. It is seeking to raise $12 million to $15 million in the initial public offering. It has ... |
| 27.06.2023 | Creating a buzz: Georgia biotech company picks up another $4.5M for honeybee vaccine | - |
| 04.01.2023 | Houston biotech company closes IPO in $15.25M deal | A clinical-stage biotech company based in Houston has announced the closing of its $15.25 million IPO. Coya Therapeutics, now trading under the ticker COYA, announced this week that its IPO — previously disclosed in December — has closed it... |
| 17.10.2022 | Biotech company raises £2.4m for ‘breakthrough’ TB test | A Nottingham company which has devised a blood test that could revolutionise management of tuberculosis (TB) has raised a further £2.4m to further develop the test and support clinical trials. |
Show more